| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $2.38B | $2.26B | $2.35B | $2.24B | $2.29B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $452.00M | $2.00M | $52.00M | $177.11M | $200.08M |
| SG&A | $573.48M | $236.67M | $249.75M | $227.30M | $182.83M |
| Operating Income | $1.56B | $1.29B | $1.49B | $307.06M | $1.43B |
| Interest Expense | – | – | $187.19M | $187.96M | $166.14M |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | $770.95M | $858.98M | $1.13B | $42.83M | $619.73M |
| EPS (basic) | 1.7900 | 1.9200 | 2.5400 | 0.1000 | 1.4900 |
| EPS (diluted) | 1.7800 | 1.9100 | 2.5300 | 0.1000 | 1.4900 |
| Shares (diluted) | $564.46M | $594.11M | $602.90M | $437.97M | $414.80M |